Wendy Osborne, MBBS (Hons), MRCP, FRCPath, of Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, gives an overview of…
Browsing: Lymphoma
While there has been a range of new therapeutic options emerging for lymphoma, this introduces the challenge of assessing them…
Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, describes his role in a…
Stephen Robinson, MBBS, MRCP, MRCPath, PhD, of University Hospitals Bristol NHS Foundation Trust, Bristol, UK, speaks to us about one…
MATRix immunochemotherapy induction therapy has produced promising results in the recent IELSG32 trial (NCT01011920) for primary CNS lymphoma (PCNSL). However,…
The multitude of novel therapies present within the field of lymphoma has inevitably given rise to an assortment of challenges.…
Up-and-coming mutation analyses are facilitating the precision treatment of lymphoma. Here, Jude Fitzgibbon, BA, PhD, of the Barts Cancer Institute,…
The Genomics England program could play a key role in personalizing the treatment of patients with follicular lymphoma, through helping…
Michelle Dawson, MD, AstraZeneca, talks about Acalabrutinib (Calquence) Approved For relapsed or refractory mantle cell lymphoma at Annual Meeting 2018.
Dr. Meletios A. Dimopoulos, MD, National and Kapodistrian University of Athens, explains Innovate Trial – Randomized Placebo Control 150 patients…